HK1119386A1 - Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo - Google Patents

Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo

Info

Publication number
HK1119386A1
HK1119386A1 HK08106821.4A HK08106821A HK1119386A1 HK 1119386 A1 HK1119386 A1 HK 1119386A1 HK 08106821 A HK08106821 A HK 08106821A HK 1119386 A1 HK1119386 A1 HK 1119386A1
Authority
HK
Hong Kong
Prior art keywords
dimenhydrinate
tablet
release preparation
preparation containing
type controlled
Prior art date
Application number
HK08106821.4A
Other languages
English (en)
Inventor
Gernot Francas
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of HK1119386A1 publication Critical patent/HK1119386A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08106821.4A 2005-03-23 2008-06-19 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo HK1119386A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005014141A DE102005014141B4 (de) 2005-03-23 2005-03-23 Tablettenförmige Retardzubereitung gegen Schwindel
PCT/DE2006/000547 WO2006099865A2 (de) 2005-03-23 2006-03-23 Tablettenförmige retardzubereitung enthaltend cinnarizin und dimenhydrinat gegen schwindel

Publications (1)

Publication Number Publication Date
HK1119386A1 true HK1119386A1 (en) 2009-03-06

Family

ID=36741196

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106821.4A HK1119386A1 (en) 2005-03-23 2008-06-19 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo

Country Status (15)

Country Link
US (1) US20090175941A1 (xx)
EP (1) EP1928459B1 (xx)
JP (1) JP2008534452A (xx)
KR (1) KR20070121705A (xx)
CN (1) CN101141962B (xx)
AT (1) ATE477802T1 (xx)
BR (1) BRPI0607409A2 (xx)
CA (1) CA2602210C (xx)
DE (2) DE102005014141B4 (xx)
DK (1) DK1928459T3 (xx)
ES (1) ES2349998T3 (xx)
HK (1) HK1119386A1 (xx)
PT (1) PT1928459E (xx)
RU (1) RU2401109C2 (xx)
WO (1) WO2006099865A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel
CN101610757B (zh) * 2006-12-15 2013-08-28 堪匹那荷兰控股公司 延长释放赋形剂及其应用
EP1935411A1 (en) 2006-12-15 2008-06-25 Campina Nederland Holding B.V. Slow release excipient and its use
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
WO2011024029A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination
DE102011051304A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Wirkstoffmatrix
DE102011053068A1 (de) * 2011-08-29 2013-02-28 Hennig Arzneimittel Gmbh & Co. Kg Darreichungsform mit stabilisierten Wirkstoffpartikeln
DE102012105512A1 (de) * 2012-06-25 2014-04-24 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur verlängerten Freisetzung von Wirkstoffen
US20150343067A1 (en) * 2012-12-27 2015-12-03 Hennig Arzneimittel Gmbh & Co. Kg, Monolithic Dosage Form for the Modified Release of an Active Ingredient Combination
FR3020571B1 (fr) * 2014-05-05 2017-08-25 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Co-granules de gomme de xanthane et de gomme d'acacia
PL2959887T3 (pl) * 2014-06-26 2019-07-31 Hennig Arzneimittel Gmbh&Co. Kg Środek leczniczy do leczenia zawrotów głowy różnego pochodzenia
CN105395504B (zh) * 2015-11-26 2019-06-28 郑州百瑞动物药业有限公司 一种盐酸氟桂利嗪骨架缓释片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel

Also Published As

Publication number Publication date
RU2401109C2 (ru) 2010-10-10
WO2006099865A2 (de) 2006-09-28
DE102005014141A1 (de) 2006-09-28
RU2007137434A (ru) 2009-04-27
EP1928459B1 (de) 2010-08-18
BRPI0607409A2 (pt) 2009-09-01
KR20070121705A (ko) 2007-12-27
WO2006099865A3 (de) 2006-12-21
DE502006007702D1 (de) 2010-09-30
ATE477802T1 (de) 2010-09-15
US20090175941A1 (en) 2009-07-09
DK1928459T3 (da) 2010-11-22
EP1928459A2 (de) 2008-06-11
CN101141962A (zh) 2008-03-12
CA2602210C (en) 2013-05-14
PT1928459E (pt) 2010-11-15
ES2349998T3 (es) 2011-01-14
DE102005014141B4 (de) 2006-12-21
CA2602210A1 (en) 2006-09-28
JP2008534452A (ja) 2008-08-28
CN101141962B (zh) 2012-07-04

Similar Documents

Publication Publication Date Title
HK1119386A1 (en) Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
HK1112404A1 (en) Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo
WO2006124047A3 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
TW200711652A (en) Method and composition for pharmaceutical product
MY143795A (en) Tetrahydropyridoindole derivatives
ZA200708304B (en) Dipeptidyl Peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
ATE478658T1 (de) Zur verhinderung von missbrauch entworfene, feste arzneimittelform zur oralen verabreichung
IL187475A (en) A form of oral administration containing one population of micro-particles to release a variable of at least one active anesthetic and a second population of micro-particles containing at least one depressant and their use
IL221770A (en) Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug
IL183108A (en) Triazole Compounds, Containing and Using Pharmaceutical Preparations for the Treatment of Prosperity Irregularities
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
TW200800998A (en) Phenylalanine derivatives
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
ATE554827T1 (de) Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff
ATE553750T1 (de) Feste orale mikropartikelförmige darreichungsform zum schutz vor missbrauch
IL197212A0 (en) Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
TWI368521B (en) A spontaneous pharmaceutical composition for treatment and prevention of proliferative diseases,uses and preparation thereof
EP1952818A4 (en) OSTEOCLASTICIZATION PREPARATION, ORAL AGGREGATION AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES WITH LACTOFERRIN-CONTAINING LIPOSOME
IL207928A (en) Pharmacotherapeutic agent that contains an active drug (mtx) and helps 2, 2-anhydropyrimidine to reduce and use mtx toxicity
TW200634002A (en) Chemical compounds
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
EP2801358A3 (en) The use of nicotine for diminishing pain in renal region in humans
TW200616680A (en) Solid medical preparation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140323